(Q39990832)

16 September 2017

title

Primary neural stem/progenitor cells expressing endostatin or cytochrome P450 for gene therapy of glioblastoma (English)

1 reference

16 September 2017

0 references

A Lorico

1

1 reference

16 September 2017

J Mercapide

2

1 reference

16 September 2017

V Solodushko

3

1 reference

16 September 2017

M Alexeyev

4

1 reference

16 September 2017

O Fodstad

5

1 reference

16 September 2017

G Rappa

6

1 reference

16 September 2017

publication date

18 April 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

15

1 reference

16 September 2017

issue

9

1 reference

16 September 2017

page(s)

605-615

1 reference

https://scigraph.springernature.com/pub.10.1038/cgt.2008.23

16 September 2017

exact match

0 references

cites work

Development of novel targeted therapies in the treatment of malignant glioma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Stem cells in the central nervous system

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Gene therapy of experimental brain tumors using neural progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Tumor-targeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Immortalized neural stem cells differ from nonimmortalized cortical neurospheres and cerebellar granule cell progenitors.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Efficient expansion and gene transduction of mouse neural stem/progenitor cells on recombinant fibronectin

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Continuous release of endostatin from microencapsulated engineered cells for tumor therapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

The functional role of CYP2B6 in human drug metabolism: substrates and inhibitors in vitro, in vivo and in silico.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Cytochrome P450 gene-directed enzyme prodrug therapy (GDEPT) for cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

The role of the bystander effect in suicide gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Prodrug-activating systems in suicide gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Forebrain-specific promoter/enhancer D6 derived from the mouse Dach1 gene controls expression in neural stem cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Design of 5' untranslated sequences in retroviral vectors developed for medical use.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectors

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Retroviral transfer of MRP1 and gamma-glutamyl cysteine synthetase modulates cell sensitivity to L-buthionine-S,R-sulphoximine (BSO): new rationale for the use of BSO in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Episomal vectors rapidly and stably produce high-titer recombinant retrovirus

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Facile whole-body imaging of internal fluorescent tumors in mice with an LED flashlight.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Antiangiogenic therapy by local intracerebral microinfusion improves treatment efficiency and survival in an orthotopic human glioblastoma model.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Structural and functional characteristics of lung macro- and microvascular endothelial cell phenotypes

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Gamma-glutamylcysteine synthetase and L-buthionine-(S,R)-sulfoximine: a new selection strategy for gene-transduced neural and hematopoietic stem/progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Murine leukemia induced by retroviral gene marking

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

The future of gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Adenovirus-mediated human endostatin gene delivery demonstrates strain-specific antitumor activity and acute dose-dependent toxicity in mice

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Local endostatin treatment of gliomas administered by microencapsulated producer cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Endostatin therapy reveals a U-shaped curve for antitumor activity

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Estimation of growth fraction with bromodeoxyuridine in human central nervous system tumors.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Cytochrome P-450 2C9 sensitizes human prostate tumor cells to cyclophosphamide via a bystander effect

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Experimental tumor therapy in mice using the cyclophosphamide-activating cytochrome P450 2B1 gene

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Mammalian neural stem cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Immunomodulatory neural stem cells for brain tumour therapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Spontaneous human adult stem cell transformation.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.23

7 January 2021

Identifiers

DOI

10.1038/CGT.2008.23

1 reference

Dimensions Publication ID

16 September 2017

1000516252

0 references

1 reference